Overall, the expression patterns observed in neuroblastoma MYCN-amplified samples were in line with the expression of these genes in MYCNARB1PRO, suggesting a broader implication for the observed signatures in MYCN-amplified cancers beyond retinoblastoma. This evidence concerns the gene MYCN and retinoblastoma.